"Executive Summary Angiotensin Converting Enzyme (ACE) Inhibitors Market Value, Size, Share and Projections The global Angiotensin Converting Enzyme (ACE) inhibitors market size was valued at USD 3.80 billion in 2024 and is expected to reach USD 5.57 billion by 2032, at a CAGR of 4.90% during the forecast period The large scale Angiotensin Converting Enzyme (ACE)...

Blood pressure disorders continue expanding globally, with WHO documenting over 1.2 billion affected individuals representing a massive healthcare burden. This widespread cardiovascular pathology progresses asymptomatically while dramatically increasing mortality risks through coronary artery disease, stroke events, and kidney dysfunction. Despite numerous pharmaceutical interventions,...